In the December 4, 2014, Federal Register, FDA issued a final rule amending its regulations governing the content and format of human prescription drug and biological products for indications involving reproduction.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.